Insider Transactions in Q2 2023 at Bionik Laboratories Corp. (BNKL)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2023
|
Andre Jacques Auberton Herve Director |
BUY
Conversion of derivative security
|
Indirect |
186,111
+14.37%
|
$0
$0.6 P/Share
|
|
Jun 13
2023
|
Remi Gaston Dreyfus Director |
BUY
Conversion of derivative security
|
Indirect |
3,102,878
+38.69%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Andre Jacques Auberton Herve Director |
BUY
Open market or private purchase
|
Indirect |
650,000
+41.32%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Remi Gaston Dreyfus Director |
BUY
Open market or private purchase
|
Indirect |
180,555
+9.05%
|
$0
$0.6 P/Share
|
|
Jun 09
2023
|
Charles Matine Director |
BUY
Open market or private purchase
|
Direct |
180,555
+46.59%
|
$0
$0.6 P/Share
|